Galecto, Inc. (GLTO)

NASDAQ

$--

(--)

Regular Market

Galecto, Inc. (GLTO) Live Price Chart

Last updated: ⁦2026-10-20 14:34:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Galecto, Inc. (GLTO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Galecto, Inc. (GLTO) Stock Price Today

Galecto, Inc. (GLTO) is currently trading at $-- as of --, -- from the previous close of $--

During today's regular trading session, GLTO has traded between $-- and $--, with a trading volume of -- shares. The current price is -- of today's range.

Galecto, Inc. (GLTO) 7-Day Stock Price Change

Over the past seven days, Galecto, Inc. (GLTO) moved from $28.98 to $28.69, representing a decline of 1.00% ($0.29).

The stock traded between $26.43 and $31.86 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 184.14 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

What is Galecto, Inc. (GLTO)?

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

Galecto, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	5
Exchange	NASDAQ
Company Website	https://www.galecto.com

How to Buy Galecto, Inc. (GLTO) Stock on MEXC

Eligible investors can buy real shares of Galecto, Inc. (GLTO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for GLTO and Place Your Order

Open the RealStocks trading page and search for GLTO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Galecto, Inc. (GLTO) stock price today?

Galecto, Inc. (GLTO) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is GLTO stock going up or down today?

As of --, GLTO is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is GLTO pre-market price?

As of --, GLTO is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is GLTO after-hours price?

As of --, GLTO is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is GLTO stock trading now?

GLTO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does GLTO sit relative to its 52-week high and low?

Over the past 52 weeks, GLTO has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Galecto, Inc. in?

Galecto, Inc. (GLTO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Galecto, Inc.'s market capitalization and where is it listed?

Galecto, Inc. is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is GLTO valued in terms of P/E ratio and EPS?

GLTO trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Galecto, Inc. pay a dividend?

Galecto, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.